#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    HER2 gene amplification Mantle cell lymphoma stage III Rosai-Dorfman syndrome Mantle cell lymphoma stage IV Fibrous dysplasia of bone Skin cancer Ewing's sarcoma recurrent Noonan syndrome Bronchopulmonary dysplasia Acute on chronic liver failure Immunodeficiency Penile squamous cell carcinoma CDKL5 deficiency disorder Central nervous system neoplasm Vernal keratoconjunctivitis More trials…

    Learn about Rare Diseases

    Haemophilia B with anti factor IX – Life with Disease Acquired haemophilia – Basic Information Synovial sarcoma – Trials in Disease Carcinoid syndrome Lennox-Gastaut syndrome Behcet’s syndrome – Trials in Disease Testicular leiomyosarcoma – Trials in Disease Congenital hypotransferrinaemia – Trials in Disease Cystic fibrosis – Diagnostics Waldenstrom’s macroglobulinaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elasomeran Larotrectinib Sulfate Efpegerglucagon Deutivacaftor Elexacaftor Benztropine Mesylate Clofutriben Dactylis Glomerata Protease Etuvetidigene Autotemcel SEVABERTINIB Nitrous Oxide Demeclocycline Hydrochloride S230815-2 Valganciclovir Hydrochloride Tiotropium Ritonavir Isavuconazonium Sulfate Calcium Folinate Pentahydrate Pimecrolimus More therapies…

    Learn about Your Condition

    Prader-Willi syndrome Brain injury Chronic sinusitis Staphylococcal infection Death neonatal Pancreatic fistula Craniotomy Tumour of ampulla of Vater Myocarditis post infection Radiation skin injury Delirium Microvillous inclusion disease Anxiety Ewing's sarcoma Anal squamous cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Remibrutinib
    • Omalizumab
    Bulgaria Czechia France Germany Hungary Italy +4

  • Study on Long-Term Spesolimab Treatment for Patients with Generalized Pustular Psoriasis from Previous Trials

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pustular psoriasis
    Investigated Drugs:
    • Spesolimab
    Belgium France Germany Italy Spain

  • Study on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Kappa Monoclonal Antibody Against Interleukin 18
    Bulgaria Czechia France Germany Greece Italy +2

  • Study on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds

    Not recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
    Germany

  • Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

    Not recruiting

    3 1
    Investigated Drugs:
    • Dersimelagon Phosphate
    Bulgaria Czechia France Italy The Netherlands Poland +1

  • Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Anb032
    • Betamethasone Dipropionate
    • Hydrocortisone
    Czechia Poland
Previous Page
1 … 46 47 48 49 50 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!